Last Updated on September 6, 2025 by The Health Master
Misleading
Telangana’s Health Minister Damodar Rajanarsimha instructs the Drug Control Authority Telangana (DCA Telangana) that misleading drug advertisements will not be tolerated and the selling of dangerous, not-of-standard-quality (NSQ) drugs is unacceptable.
The minister met with the DCA Telangana following a review of their recent operations.
Yet even though many were brought to action due to regulatory compliance from DCA Telangana inspections, more than 186 samples were declared as NSQs out of 7200 samples secured.
Thus, the meeting was not one of rebuke, but rather one of stringent mandates to ensure the quality of medications utilized moving forward.
DCA Telangana efforts
During the meeting, the Health Minister praised the DCA Telangana for their inspections and rapid action taken against the defaulters but stated that drug control is a life-and-death matter and therefore, further efforts are necessary to ensure that the deeds have been done to clean out the marketplace of dangerous possibilities and that the worst offenders will not return to the marketplace ever again.
The key directives:
- Punish All Involved: Everyone who had a hand in the selling of fake, NSQ drugs should be tried, convicted, and imprisoned.
- Attack Misleading Advertising: Anyone engaged in fake advertising to mislead customers into purchasing fake products should be found.
- Close Repeat Offenders: Any company that’s engaged in poor quality control should be shut down for good.
- Implement the PD Act: The Preventive Detention (PD) Act should be applied for anyone manufacturing/selling drugs that are dangerous and already banned.
- Penalize Prescription Liberation: Measures should be taken to ensure antibiotics and narcotic-level drugs are NOT dispensed without prescription; this is critical for the global antibiotic resistance campaign.
- Ensure DCA Telangana’s Growth: The drug testing lab upgrade should be expedited; hire more drug inspectors as necessary.
Q: What are the telltale signs of fake or not-of-standard-quality (NSQ) drugs?
A: Fake drugs have different packaging, a different color or odor, and may not provide the effect one expects. They might also have misspellings on the label or be priced at an inexplicably low price.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
New Advisory: Delhi Curbs Misuse of Pregabalin and Tapentadol
USFDA Inspection: At Zydus with Zero observations
Key Notes on Revised Schedule M: Plant and equipment
Drug recall: Alembic recalls 9,492 bottles of Doxepin Capsules
Focus on R&D, secure Patents for New Drugs: PM
Big Push for Safer Medicines: Launches “SHRESTH” to rank States
Drug recall: Sun Pharma recalls 11,328 bottles of BP drug
New Draft Standards for IVD Medical Devices: CDSCO
